| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.38B | 227.82B | 189.42B | 158.10B | 129.45B | 120.82B |
| Gross Profit | 212.15B | 171.08B | 136.67B | 140.93B | 122.68B | 104.14B |
| EBITDA | 100.06B | 81.19B | 64.45B | 46.64B | 42.85B | 30.89B |
| Net Income | 71.71B | 53.32B | 39.46B | 27.90B | 26.42B | 18.09B |
Balance Sheet | ||||||
| Total Assets | 9.39T | 9.20T | 9.26T | 8.55T | 8.54T | 8.55T |
| Cash, Cash Equivalents and Short-Term Investments | 1.12T | 1.12T | 1.17T | 1.37T | -1.52T | -1.42T |
| Total Debt | 913.29B | 988.22B | 1.80T | 1.05T | 974.05B | 1.62T |
| Total Liabilities | 8.52T | 8.40T | 8.42T | 7.79T | 7.81T | 7.81T |
| Stockholders Equity | 872.65B | 802.43B | 842.74B | 759.53B | 724.68B | 732.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 31.28B | 5.18B | 3.73B | 4.26B | 14.25B |
| Operating Cash Flow | 0.00 | 45.95B | 11.45B | 6.42B | 6.77B | 17.10B |
| Investing Cash Flow | 0.00 | -65.19B | -746.11B | -100.76B | 89.18B | 45.24B |
| Financing Cash Flow | 0.00 | -31.22B | 538.17B | -52.35B | 1.89B | 632.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥101.82B | 1.54 | ― | 3.05% | 8.75% | -12.68% | |
70 Outperform | ¥527.58B | 15.28 | 6.09% | 2.93% | 5.87% | 50.22% | |
70 Outperform | ¥574.45B | 9.42 | ― | 3.21% | 19.82% | 29.59% | |
69 Neutral | ¥67.24B | 6.31 | ― | 2.34% | -0.97% | 27.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥963.61B | 8.76 | ― | 2.10% | 1.39% | 52.58% | |
65 Neutral | ¥11.00B | 8.64 | ― | 2.74% | 7.74% | -92.49% |